Additional Biopsies After CRC Biopsy Not Tied to Metachronous CRC
Biopsy of nontumor sites after initial colorectal cancer biopsy was not linked to a risk for metachronous cancer.
Colorectal Cancer
Decreases in Breast, Cervical Cancer Screening From 2018 to 2020
The prevalence of screening for colorectal cancer remained stable.
Eating Red Meat May Up Colorectal Cancer Risk in Black Women
Eating unprocessed red meat is associated with an increased risk of colorectal cancer in Black women.
Optimal Treatment Sequence for RAS/BRAF Wild-Type Metastatic Colorectal Cancer Still Unclear
There were no significant differences in most efficacy outcomes between 2 treatment sequences.
Intermittent FOLFIRI With Panitumumab Improves Outcomes in Metastatic Colorectal Cancer
A new study in untreated metastatic colorectal cancer met its progression-free survival endpoint for intermittent treatment with FOLFIRI and panitumumab.
Modified FOLFOX6 With Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer
Patients with RAS wild-type metastatic colorectal cancer had an improvement in overall survival when modified FOLFOX6 was combined with panitumumab vs bevacizumab.
Fecal Hemoglobin Concentration May Predict Advanced Neoplasia, Colorectal Cancer
Researchers developed and assessed logistic prediction models for the detection of advanced neoplasia and colorectal cancer.
Real-World Data Differ From Trial Data for Some Gastrointestinal Cancer Drugs
Adding nab-paclitaxel to gemcitabine did not appear to improve survival in a real-world cohort.
Colonoscopy Before Age 50 May Cut Colorectal Cancer Risk in Women
New research supports starting colorectal cancer screening before 50 years of age in women.
Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...